STAN375i-961C1
**Upon testing, the current lot of material did not meet WiCell’s standards for quality, and it is therefore unavailable. WiCell is working with the Provider to obtain replacement materials for distribution. To be notified of the status of this cell line please submit your information here.| Cell Line Alias | ISMMS 961i C1 |
| Cell Type | Human iPS |
| Disease | None reported |
| Sex | Male |
| Age at Collection | 57 Years |
| Ethnicity | Caucasian |
| Ethnicity Information | Self-reported |
| Genetically Related Cell Lines | |
| Reprogramming Method | Sendai Virus (Oct4, Klf4, Sox2, Myc) |
| Tissue Origin | Blood |
| Provider | Stanford University - Dr. Thomas Quertermous |
| dbGaP Data | |
| hPSCReg ID | |
| NIH Approval | |
| Pub Med Abstract | |
| Collection(s) | NHLBI Next Gen - Insulin resistance syndrome (Dr. Thomas Quertermous, Stanford University) |
Current Lot Information
| Lot Number | Culture Platform | Lot Description | Passage Number | Banked By | Protocol | Product Information & Testing |
|---|---|---|---|---|---|---|
| DB44656 | mTeSR1/Matrigel | 10 | Provider | WiCell Feeder Independent Pluripotent Stem Cell Protocol |
